Houses of the Oireachtas

All parliamentary debates are now being published on our new website. The publication of debates on this website will cease in December 2018.

Go to oireachtas.ie

White, Alex

Wednesday, 24 April 2013

Dáil Éireann Debate
Vol. Nbr.


Health (Pricing and Supply of Medical Goods) Bill 2012 [Seanad]: Order for Report Stage

I move: "That Report Stage be taken now."More Button

Health (Pricing and Supply of Medical Goods) Bill 2012 [Seanad]: Report Stage (Continued)

As Deputy Caoimhghín Ó Caoláin identified, the amendments in the next group deal more specifically with AEDs but we have started the debate in this group. The specifics of AEDs is more germane to ...More Button

This approach is consistent with the recommendations set out in the Department of Health-HSE report entitled, Proposed Model of Reference Pricing and Generic Substitution, or the so-called Moran re...More Button

While some countries maintain a negative list of interchangeable medicinal products, I do not consider it appropriate to maintain both a positive and a negative list in this Bill, which is what i...More Button

I thank Deputies Murphy and Shortall for their overall support for what this Bill seeks to achieve and I very carefully note it. I agree with what Deputy Murphy and others have said about the co...More Button

Deputy Naughten and others asked me to genuinely consider this issue, which I have done. I have thought very carefully about it, as a Minister should, have met representatives of the Irish Epile...More Button

I emphasise the point, as I did on the last occasion, that we are not substituting medicines in this exercise. What I am asking the House to do is to agree to a statutory regime to be put in pla...More Button

The expert body, the Irish Medicines Board in this instance, should have the level of trust not just from this House but publicly to do what it is required to do. It must follow - I refer to Dep...More Button

Deputy Naughten said that will not happen. It may not happen but it is a matter for the Irish Medicines Board - the people who are expert and who must carry out this work in the context of the r...More Button

I think Deputy Murphy raised the question of the UK. I can advise the House that there is no official list of medicines considered unsuitable for generic prescribing in the UK but the national p...More Button

I mentioned the Moran report about which we should be absolutely clear. That report referred to medicines and types of medicines which, in general, would not be regarded as interchangeable. App...More Button

I fully appreciate the points Deputies raised and the concerns they have but the job we are being asked to do is to set out a statutory framework. Let us put in place a statutory framework and r...More Button

The report does not recommend that.More Button

The fear that Deputy Naughten talked about is the fear of something that may happen in the future. The fact is that we are giving direction. Deputy Ó Caoláin should note that we will be giving di...More Button

We are giving a direction in that regard.

  On the question of safety, interchangeability and the experience overseas, there are six main classes of anti-epileptic drugs, AEDs,...More Button

Health (Pricing and Supply of Medical Goods) Bill 2012 [Seanad]: Report Stage (Resumed) (Continued)

Is this by statute or is it in accordance with rules that are established under statute? It is important to tell the House that.More Button

No. I am carefully following the Deputy's point.More Button

This may be of help. What I am asking is whether the countries on the list the Deputy gave are countries in which the relevant authority - the equivalent of the Irish Medicines Board - has decided...More Button

Or to include them.More Button

I have, and I will again.More Button

It should not be assumed that because a Minister or Minister of State stands up and disagrees with issues raised by colleagues on the opposite side of the House, that he is not listening to them or...More Button

I mentioned earlier that in addition to the responsibilities I have as Minister of State, I am aware of the issue being raised here in regard to anti-epileptic drugs. Even if I was not aware of ...More Button

I am not taking a view that I have been told I have to take. I know Deputy Róisín Shortall and I am quite sure she went through the documentation, the arguments and the issues carefully when she w...More Button

Orthodontic Service Provision

The HSE provides orthodontic treatment to patients based on their level of clinical need. An individual's access to orthodontic treatment is determined against a set of clinical guidelines and pri...More Button

Medical Card Withdrawals

I have asked the Health Service Executive for a report on the issue raised by the Deputy. I will revert to the Deputy on the matter as soon as possible.More Button

Medical Card Appeals

The Health Service Executive has been asked to examine this matter and to reply to the Deputy as soon as possible. The Health Service Executive operates the General Medical Services scheme, which ...More Button

Orthodontic Service Waiting Lists

The HSE provides orthodontic treatment to patients based on their level of clinical need. An individual's access to orthodontic treatment is determined against a set of clinical guidelines and prio...More Button

Medical Card Data

The Health Service Executive has been asked to examine this matter and to reply to the Deputy as soon as possible. The Health Service Executive operates the General Medical Services scheme, which ...More Button

The Health Service Executive has been asked to examine this matter and to reply to the Deputy as soon as possible. The Health Service Executive operates the General Medical Services scheme, which ...More Button

Medicinal Products Expenditure

The major share of HSE expenditure on drugs and medicines is in respect of items supplied under the GMS and community drug schemes. The drugs and medicines are actually purchased by community pharm...More Button

In recent years, a number of changes to the pricing and reimbursement system have been successfully introduced in Ireland. These have resulted in reductions in the prices of thousands of medicine...More Button

- significant reductions for patients in the cost of drugs,More Button

- a lowering of the drugs bill to the State, More Button

- timely access for patients to new cutting-edge drugs for certain conditions, andMore Button

- reducing the cost base of the health system into the future.More Button

The gross savings arising from this deal will be in excess of €400m over 3 years. €210 million from the gross savings will make available new drugs to patients over 3 years. Thus, the deal will r...More Button

The Department and the HSE have successfully finalised discussions with the Association of Pharmaceutical Manufacturers in Ireland (APMI), which represents the generic industry, on a new agreemen...More Button

It is estimated that the combined gross savings from the IPHA and APMI deals will be in excess of €120 million in 2013. The IPHA agreement provides that prices are referenced to the currency adj...More Button

The Health (Pricing and Supply of Medical Goods) Bill 2012, which is scheduled for Report Stage today, provides for the introduction of a system of generic substitution and reference pricing. The...More Button

- the ability of suppliers to meet patient demand for the relevant item;More Button

- the value for money afforded by the relevant item;More Button

- the equivalent prices of the relevant item in all other Member States where the product is marketed;More Button

- the prices of therapeutically similar items; and More Button

- the resources available to the HSE.More Button

It is important to balance achieving best value for money for the taxpayer with assuring continuity of supply for critical medical products, particularly in a small market like Ireland. Consequen...More Button